ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG

This study has been completed.
Study NCT00037713.   Last updated on October 29, 2008.   Information provided by ImClone Systems

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Carcinoma, Small Cell Lung
2 Additional conditions recognized in this trial
Carcinoma
Carcinoma, Small Cell
Lung Neoplasms
3 More general conditions related to this trial
Adenocarcinoma
Carcinoma, Neuroendocrine
Lung Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neuroectodermal Tumors
Neuroendocrine Tumors
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms
4 Interventions listed in this trial
BEC2 Vaccine
5 Sponsors listed in this trial
ImClone Systems
Merck KGaA
EORTC Lung Cancer Cooperative Group
Spanish Lung Cancer Group
Schweizerische Arbeitsgruppe fuer angewandte Krebsforschung (SAKK)
Centers of Veterans' Administration
Groupe Francais De Pneumo-Cancerologie
Memorial Sloan-Kettering Cancer Center
Independent centers (Australia, New Zealand, Europe, USA)




Links to all studies - primarily for crawlers